Genome-wide modulation of gene transcription in ovarian carcinoma cells by a new mithramycin analogue.
Ontology highlight
ABSTRACT: Ovarian cancer has a poor prognosis due to intrinsic or acquired resistance to some cytotoxic drugs, raising the interest in new DNA-binding agents such as mithramycin analogues as potential chemotherapeutic agents in gynecological cancer. Using a genome-wide approach, we have analyzed gene expression in A2780 human ovarian carcinoma cells treated with the novel mithramycin analogue DIG-MSK (demycarosyl-3D-β-D-digitoxosyl-mithramycin SK) that binds to C+G-rich DNA sequences. Nanomolar concentrations of DIG-MSK abrogated the expression of genes involved in a variety of cell processes including transcription regulation and tumor development, which resulted in cell death. Some of those genes have been associated with cell proliferation and poor prognosis in ovarian cancer. Sp1 transcription f
SUBMITTER: Vizcaino C
PROVIDER: S-EPMC4128730 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
ACCESS DATA